Robeco Institutional Asset Management B.V.
Position in RPRX — Royalty Pharma plc
CIK 1418773
ROTTERDAM, P7
Position in RPRX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$51,112,627
+$5,800,453 QoQ
Shares Held
911,586
-3.5% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2
of 107 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $992,672,242 across 15 Biotechnology names. RPRX ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
460,602 | $287,203,771 | |
| 2 | INCY |
Incyte Corp
|
2,441,735 | $276,795,079 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
404,396 | $200,875,625 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
188,084 | $56,618,926 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,029,819 | $56,032,451 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
911,586 | $51,112,627 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
117,612 | $28,340,963 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
408,215 | $23,358,062 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,112,627 | 911,586 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $45,312,174 | 944,594 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $36,687,598 | 949,472 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $44,051,278 | 1,248,619 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $27,892,984 | 774,160 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $19,520,004 | 627,048 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $13,998,893 | 548,761 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $14,281,782 | 504,835 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $8,949,846 | 339,395 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $2,262,413 | 74,495 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $1,417,196 | 50,452 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $222,439 | 8,196 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $281,639 | 9,162 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $848,902 | 23,561 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $2,150,994 | 54,428 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $4,263,218 | 106,103 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $3,180,452 | 75,653 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $1,271,108 | 32,626 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $210,368 | 5,279 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $190,783 | 5,279 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $216,386 | 5,279 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $230,269 | 5,279 | Shares | Defined | 2022-12-01 | |
| No filing history on record for this holder in this stock. | ||||||